Palomino Laboratories (PALX) Invested Capital (2022 - 2025)

Palomino Laboratories has disclosed Invested Capital across 4 years of filings, most recently posting $7.6 million for Q3 2025.

• In Q3 2025, Invested Capital rose 4891.69% year-over-year to $7.6 million; the TTM figure through Sep 2025 stood at $7.6 million (up 4891.69% YoY), while the FY2024 annual figure was $300.3 million, up 421297.2% from the prior year.
• Invested Capital came in at $7.6 million for Q3 2025 at Palomino Laboratories, up from -$427236.0 in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $7.6 million in Q3 2025 to a low of -$716653.0 in Q1 2025.
• Average Invested Capital over 4 years is $713474.7, with a median of $79857.5 recorded in 2023.
• The largest YoY upside for Invested Capital was 4891.69% in 2025 against a maximum downside of 910.16% in 2025.
• Over 4 years, Invested Capital stood at -$22500.0 in 2022, then surged by 416.7% to $71257.0 in 2023, then surged by 260.24% to $256694.0 in 2024, then soared by 2873.38% to $7.6 million in 2025.
• Per Business Quant data, the three most recent Invested Capital figures were $7.6 million in Q3 2025, -$427236.0 in Q2 2025, and -$716653.0 in Q1 2025.